Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease
Year: 2026
Type: article
Source: Inflammatory Bowel Diseases
DOI: 10.1093/ibd/izag101
Authors: Mahmud Hussain, Anne Y Lai, Derek Franklin, Karen Lenz, Arpita Patel, Noah Murr, Harunobu Kato, Lini Pandite, Taylor H Schreiber, Suresh de Silva
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166317127